Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal Nature Communication PR Newswire LUND, Sweden and...
Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University Rotterdam First Patient Dosed...
Bulletin from the extraordinary general meeting in Alligator Bioscience AB PR Newswire LUND, Sweden, Nov. 8, 2021 LUND, Sweden, Nov. 8, 2021...
Alligator Bioscience AB: Interim report January-September 2021 PR Newswire STOCKHOLM, Oct. 21, 2021 STOCKHOLM, Oct. 21, 2021 /PRNewswire/...
Notice of extraordinary general meeting in Alligator Bioscience AB PR Newswire STOCKHOLM, Oct. 7, 2021 STOCKHOLM, Oct. 7, 2021 /PRNewswire/...
Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the...
Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination...
Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation PR Newswire STOCKHOLM, Aug...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.